iScience (Oct 2023)

Highly sensitive visual restoration and protection via ectopic expression of chimeric rhodopsin in mice

  • Yusaku Katada,
  • Kazuho Yoshida,
  • Naho Serizawa,
  • Deokho Lee,
  • Kenta Kobayashi,
  • Kazuno Negishi,
  • Hideyuki Okano,
  • Hideki Kandori,
  • Kazuo Tsubota,
  • Toshihide Kurihara

Journal volume & issue
Vol. 26, no. 10
p. 107716

Abstract

Read online

Summary: Photoreception requires amplification by mammalian rhodopsin through G protein activation, which requires a visual cycle. To achieve this in retinal gene therapy, we incorporated human rhodopsin cytoplasmic loops into Gloeobacter rhodopsin, thereby generating Gloeobacter and human chimeric rhodopsin (GHCR). In a murine model of inherited retinal degeneration, we induced retinal GHCR expression by intravitreal injection of a recombinant adeno-associated virus vector. Retinal explant and visual thalamus electrophysiological recordings, behavioral tests, and histological analysis showed that GHCR restored dim-environment vision and prevented the progression of retinal degeneration. Thus, GHCR may be a potent clinical tool for the treatment of retinal disorders.

Keywords